Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports
(Reuters) -Pfizer is closing in on a potential $7.3 billion takeover of anti-obesity drug developer Metsera, the Financial Times reported on Sunday, citing unidentified sources. Pfizer will pay Me...
Read More






